BOCCALINI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 16.355
EU - Europa 15.869
AS - Asia 9.130
SA - Sud America 1.141
AF - Africa 272
OC - Oceania 228
Continente sconosciuto - Info sul continente non disponibili 2
Totale 42.997
Nazione #
US - Stati Uniti d'America 16.104
RU - Federazione Russa 4.297
IT - Italia 4.011
PL - Polonia 3.323
SG - Singapore 2.490
CN - Cina 1.967
HK - Hong Kong 1.258
IE - Irlanda 919
BR - Brasile 907
KR - Corea 892
VN - Vietnam 863
SE - Svezia 789
DE - Germania 533
FR - Francia 488
FI - Finlandia 431
IN - India 353
GB - Regno Unito 317
AU - Australia 218
JO - Giordania 200
TR - Turchia 182
BD - Bangladesh 171
CH - Svizzera 155
NL - Olanda 148
ID - Indonesia 143
JP - Giappone 140
CA - Canada 130
UA - Ucraina 105
AR - Argentina 91
ES - Italia 66
MX - Messico 64
ZA - Sudafrica 62
TH - Thailandia 54
CI - Costa d'Avorio 53
IR - Iran 51
PH - Filippine 51
IQ - Iraq 38
TW - Taiwan 37
EC - Ecuador 35
NG - Nigeria 35
BE - Belgio 34
PK - Pakistan 34
MY - Malesia 29
CZ - Repubblica Ceca 27
SA - Arabia Saudita 27
AE - Emirati Arabi Uniti 26
GR - Grecia 26
LT - Lituania 25
PE - Perù 24
MA - Marocco 23
VE - Venezuela 23
AT - Austria 19
CO - Colombia 19
EG - Egitto 19
CL - Cile 18
KE - Kenya 18
LV - Lettonia 18
PT - Portogallo 18
BG - Bulgaria 17
PY - Paraguay 16
HR - Croazia 14
NP - Nepal 13
SI - Slovenia 13
TN - Tunisia 13
UZ - Uzbekistan 13
AL - Albania 12
BH - Bahrain 11
KZ - Kazakistan 11
RO - Romania 11
AZ - Azerbaigian 10
JM - Giamaica 10
NO - Norvegia 10
OM - Oman 10
SC - Seychelles 8
DZ - Algeria 7
GE - Georgia 7
GT - Guatemala 7
HU - Ungheria 7
IL - Israele 7
NZ - Nuova Zelanda 7
BJ - Benin 6
CY - Cipro 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
CR - Costa Rica 5
EE - Estonia 5
GH - Ghana 5
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SV - El Salvador 5
UY - Uruguay 5
AM - Armenia 4
BY - Bielorussia 4
GA - Gabon 4
HN - Honduras 4
LK - Sri Lanka 4
Totale 42.937
Città #
Santa Clara 3.903
Warsaw 3.297
Ashburn 1.834
Singapore 1.813
Hong Kong 1.035
Dublin 911
Fairfield 897
San Jose 837
Chandler 772
Seoul 730
Milan 569
Beijing 474
Florence 413
Seattle 382
Woodbridge 368
Cambridge 363
Rome 332
Houston 328
Hefei 325
Buffalo 319
Wilmington 300
Los Angeles 268
Ho Chi Minh City 257
Princeton 256
New York 248
Lauterbourg 246
Council Bluffs 242
The Dalles 234
Lawrence 233
Altamura 229
Moscow 218
Boston 209
Mumbai 201
Hanoi 187
Ann Arbor 178
Boardman 159
Jacksonville 156
Helsinki 154
Munich 154
Melbourne 139
Bern 130
Tokyo 122
Naples 109
Shanghai 108
Jakarta 103
Kent 99
Medford 95
Dallas 88
Paris 87
Turku 85
Chicago 80
San Diego 77
São Paulo 72
Bologna 71
Izmir 70
Clifton 66
London 65
Turin 60
Dong Ket 58
Redondo Beach 58
Abidjan 53
Sydney 53
Orem 51
Palermo 50
Genoa 49
Norwalk 49
Bari 48
Frankfurt am Main 48
Montreal 42
Da Nang 41
Toronto 41
Bremen 40
Rio de Janeiro 39
Bangkok 38
Lappeenranta 38
Falkenstein 37
Dearborn 36
Figino 35
Amsterdam 34
Atlanta 34
Brooklyn 34
Cagliari 34
Abuja 31
Chennai 31
Falls Church 30
Haiphong 29
Phoenix 29
Hillsboro 28
Guangzhou 27
Tianjin 26
Catania 25
Ankara 24
Brescia 24
Johannesburg 24
Manchester 24
Yubileyny 24
Bengaluru 23
Denver 23
Andover 22
Lima 22
Totale 27.263
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 1.473
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 601
HPV vaccination for boys? A systematic review of economic studies 456
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 417
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 340
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 328
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 316
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 313
Further Considerations on the Need of a Specific BCG Vaccination Programme for Foreign New-borns 305
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: Where is the greatest benefit for cervical cancer prevention in Italy? 304
Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy 303
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 302
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 299
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 296
Human papilloma virus vaccination: impact and recommendations across the world. 293
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 279
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 276
Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy. 275
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 274
The epidemiology of mumps in Italy 267
The epidemiology of Varicella Zoster Virus infection in Italy. 256
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 255
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 254
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 252
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 248
Valutazione economica della vaccinazione anti-varicella neibambini e adolescenti italiani secondo differenti strategie diintervento: il peso dei casi ospedalizzati non complicati 242
Human Papilloma Virus Vaccination and Cervical Screening in the Italian Regions: An Overview of the Current State of the Art 237
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 230
Attitudes and perceptions of Italian Students in Healthcare Settings on COVID-19 vaccines and vaccinations strategies, one year after the immunization campaign 229
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 228
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 225
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 225
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 225
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 221
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 219
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 215
Progress in Italy in control and elimination of measles and congenital rubella. 209
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 205
Recommended vaccinations for asplenic and hyposplenic adult patients 204
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 203
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 196
Knowledge of University Students in Health Care Settings on Vaccines and Vaccinations Strategies: Impact Evaluation of a Specific Educational Training Course during the COVID-19 Pandemic Period in Italy 192
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 189
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 189
Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign 187
Vaccination coverage during pregnancy and factors associated with refusal of recommended vaccinations: An Italian cross sectional study 186
No confirmed cases of Taenia solium taeniasis in a group of recently arrived Sub-Saharan migrants to Italy 186
Determinants of Actual COVID-19 Vaccine Uptake in a Cohort of Essential Workers: An Area-Based Longitudinal Study in the Province of Prato, Italy 183
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 183
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review 181
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 180
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 179
An overview on the implementation of HPV vaccination in Europe. 179
Clinical and economic impact of a specific BCG vaccination program implemented in Prato, central Italy, involving foreign newborns on hospitalizations 177
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 177
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 176
Autocontrollo e rischio microbiologico. Ristorazione di servizio e ristorazione commerciale in un’area ad alto impatto Turistico (Isola d’Elba – Piombino) 176
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 176
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 175
Reasons for the Intention to Refuse COVID-19 Vaccination and Their Association with Preferred Sources of Information in a Nationwide, Population-Based Sample in Italy, before COVID-19 Vaccines Roll Out 175
Attitudes and Perceptions of University Students in Healthcare Settings towards Vaccines and Vaccinations Strategies during the COVID-19 Pandemic Period in Italy 173
Strategies for management of strongyloidiasis in migrants from Sub-Saharan Africa recently arrived in Italy: A cost-effectiveness analysis 173
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 172
Key points for the decision maker 172
Health literacy and vaccination: A systematic review 171
The role of health literacy in covid-19 preventive behaviors and infection risk perception: Evidence from a population-based sample of essential frontline workers during the lockdown in the province of prato (tuscany, italy) 170
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 169
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 169
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 168
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 168
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 168
Adiuvanti e vaccini coniugati 167
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 167
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 167
A study of hepatitis a seroprevalence in a paediatric and adolescent population of the province of florence (Italy) in the period 2017–2018 confirms tuscany a low endemic area 167
Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence 166
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 166
Paediatric activities and adherence to vaccinations during the COVID-19 epidemic period in Tuscany, Italy: A survey of paediatricians 164
Quality and safety of vaccines manufacturing: An online survey on attitudes and perceptions of italian internet users 164
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 163
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 162
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 162
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) 162
The expected impact of new vaccines and vaccination policies. 161
Economic evaluation of Varicella vaccination: results of a systematic review. 161
La sorveglianza di laboratorio dei casi di sospetto morbillo in Toscana dal 2004 al 2012. 161
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population 161
Vaccine production process: How much does the general population know about this topic? a web-based survey 161
Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy) 160
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 160
Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. 160
A study of varicella seroprevalence in a pediatric and adolescent population in florence (Italy). natural infection and vaccination-acquired immunization 160
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 155
Impact assessment of an education course on vaccinations in a population of pregnant women: A pilot study 155
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 155
Impact assessment of an educational course on vaccinations in a population of medical students 155
A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012: Implications for immunization policies 154
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 154
Sieroprevalenza verso l’epatite A nella popolazione pediatrica e adolescente della provincia di Firenze 154
The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile 153
Totale 22.471
Categoria #
all - tutte 117.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.537 58 207 77 67 38 39 58 123 39 65 270 496
2022/20234.261 369 677 224 278 268 760 560 238 541 33 148 165
2023/20242.616 91 209 311 174 223 301 198 374 109 220 229 177
2024/202512.589 463 1.317 817 1.868 3.451 1.667 255 653 595 393 508 602
2025/202614.419 1.611 1.783 1.109 966 1.456 496 1.809 621 1.089 1.064 526 1.889
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 43.307